Ruzsics Z - Search Results

1

IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.

Hahn F, Wangen C, Häge S, Peter AS, Dobler G, Hurst B, Julander J, Fuchs J, Ruzsics Z, Überla K, Jäck HM, Ptak R, Muehler A, Gröppel M, Vitt D, Peelen E, Kohlhof H, Marschall M. Hahn F, et al. Among authors: ruzsics z. Viruses. 2020 Dec 5;12(12):1394. doi: 10.3390/v12121394. Viruses. 2020. PMID: 33291455 Free PMC article.

2

Analysis of the hexon gene sequence of bovine adenovirus type 4 provides further support for a new adenovirus genus (Atadenovirus).

Dán A, Ruzsics Z, Russell WC, Benkö M, Harrach B. Dán A, et al. Among authors: ruzsics z. J Gen Virol. 1998 Jun;79 ( Pt 6):1453-60. doi: 10.1099/0022-1317-79-6-1453. J Gen Virol. 1998. PMID: 9634088

3

Author Correction: Molecular mechanism for the control of virulent Toxoplasma gondii infections in wild-derived mice.

Murillo-León M, Müller UB, Zimmermann I, Singh S, Widdershoven P, Campos C, Alvarez C, Könen-Waisman S, Lukes N, Ruzsics Z, Howard JC, Schwemmle M, Steinfeldt T. Murillo-León M, et al. Among authors: ruzsics z. Nat Commun. 2019 Apr 4;10(1):1645. doi: 10.1038/s41467-019-09648-2. Nat Commun. 2019. PMID: 30948711 Free PMC article.

4

Neonatal immune challenge poses a sex-specific risk for epigenetic microglial reprogramming and behavioral impairment.

Schwabenland M, Mossad O, Sievert A, Peres AG, Ringel E, Baasch S, Kolter J, Cascone G, Dokalis N, Vlachos A, Ruzsics Z, Henneke P, Prinz M, Blank T. Schwabenland M, et al. Among authors: ruzsics z. Nat Commun. 2023 May 11;14(1):2721. doi: 10.1038/s41467-023-38373-0. Nat Commun. 2023. PMID: 37169749 Free PMC article.

5

Multiple enlargements in the right inverted terminal repeat of the DNA of canine adenovirus type 2.

Fejér G, Berencsi G, Ruzsics Z, Belák S, Linné T, Nász I. Fejér G, et al. Among authors: ruzsics z. Acta Microbiol Hung. 1992;39(2):159-68. Acta Microbiol Hung. 1992. PMID: 1307439

6

Characterization of an intermediate adenovirus strain.

Fejér G, Kiss A, Lengyel A, Ruzsics Z, Berencsi G, Nász I. Fejér G, et al. Among authors: ruzsics z. Acta Microbiol Hung. 1990;37(3):315-8. Acta Microbiol Hung. 1990. PMID: 2100904

7

Molecular mechanism for the control of virulent Toxoplasma gondii infections in wild-derived mice.

Murillo-León M, Müller UB, Zimmermann I, Singh S, Widdershooven P, Campos C, Alvarez C, Könen-Waisman S, Lukes N, Ruzsics Z, Howard JC, Schwemmle M, Steinfeldt T. Murillo-León M, et al. Among authors: ruzsics z. Nat Commun. 2019 Mar 15;10(1):1233. doi: 10.1038/s41467-019-09200-2. Nat Commun. 2019. PMID: 30874554 Free PMC article.

8

Partial inhibition of amplifications by primers of EHEC genes.

Gadó I, Ruzsics Z, Tóth I, Király M, Milch H. Gadó I, et al. Among authors: ruzsics z. Acta Microbiol Immunol Hung. 1998;45(2):239-52. Acta Microbiol Immunol Hung. 1998. PMID: 9768292

9

Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures.

Stepanenko AA, Sosnovtseva AO, Valikhov MP, Chernysheva AA, Cherepanov SA, Yusubalieva GM, Ruzsics Z, Lipatova AV, Chekhonin VP. Stepanenko AA, et al. Among authors: ruzsics z. Mol Ther Oncolytics. 2021 Dec 21;24:230-248. doi: 10.1016/j.omto.2021.12.013. eCollection 2022 Mar 17. Mol Ther Oncolytics. 2021. PMID: 35071746 Free PMC article.

10

Production of antibodies against adenovirus hexons in Escherichia coli by recombinant phages (a note).

Ruzsics Z, Takács T, Adám E, Nász I. Ruzsics Z, et al. Acta Microbiol Immunol Hung. 1994;41(4):473-4. Acta Microbiol Immunol Hung. 1994. PMID: 7866732

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters